Abstract
Sera from 45 patients from The Netherlands, Germany and Belgium who had a clinical diagnosis of haemolytic uraemic syndrome (HUS) were screened for antibodies to the lipopolysaccharide (LPS) ofEscherichia coli producing Verocytotoxin (VTEC). Sera from 43 family contacts and 34 control patients were also examined. Using the techniques of EIA and immunoblotting, antibodies to the LPS ofEscherichia coli O157 were found in 28 patients, and to the LPS of serogroups O115 and O145 in one patient and one family member respectively. The results of our study suggest that VTEC, and in particularEscherichia coli O157, might be a significant cause of HUS in Western Europe.
Similar content being viewed by others
References
Karmali MA Infection by Verocytotoxin-producingEscherichia coli. Clinical Microbiological Reviews 1989, 2: 15–38.
Kleanthos H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV Haemolytic uraemic syndrome in the British Isles, 1985–1988; association with Vero cytotoxin-producingEscherichia coli. II: Microbiological aspects. Archives of Diseases of Childhood 1990, 65: 722–727.
Smith HR, Scotland SM Verocytotoxin-producing strains ofEscherichia coli. Journal of Medical Microbiology 1988, 26: 77–85.
Milford DV, Taylor CM, Gutteridge B, Hall S, Rowe B, Kleanthos H Haemolytic uraemic syndrome in the British Isles, 1985–1988; association with Vero cytotoxin-producingEscherichia coli. I: Clinical and epidemiological aspects. Archives of Diseases of Childhood 1990, 65: 716–721.
Chart H, Rowe B Serological identification of infection by Verocytotoxin producingEscherichia coli in patients with haemolytic uraemic syndrome. Serodiagnosis and Immunotherapy in Infectious Disease 1990, 4: 413–418.
Chart H, Scotland SM, Rowe B Serum antibodies toEscherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. Journal of Clinical Microbiology 1989, 27: 285–290.
Chart H, Scotland SM, Smith HR, Rowe B Antibodies toEscherichia coli in patients with haemorrhagic colitis and haemolytic uraemic syndrome. Journal of Clinical Pathology 1989, 42: 973–976.
Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CV Serological identification ofEscherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991, 337: 138–140.
Chart H, Rowe B, van der Kar N, Monnens LAH Serological identification ofEscherichia coli O157 as cause of haemolytic uraemic syndrome in Netherlands. Lancet 1991, 337: 437.
Bitzan M, Moebius E, Ludwig K, Muller-Wiefel DE, Heesemann J, Karch H High incidence of serum antibodies toEscherichia coli O157 lipopolysaccharide in children with hemolytic uremic syndrome. Journal of Pediatrics 1991, 119: 380–385.
Caprioloi A, Luzzi I, Rosmini F, Pasquini P, Cirrincione R, Gianviti, Chiara Matteucci M, Rizzoni G Haemolytic uraemic syndrome and Vero cytotoxin-producingEscherichia coli infection in Italy. Journal of Infectious Diseases 1991, 119: 154–158.
Westphal O, Jahn K Bacterial lipopolysaccharide: extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry 1965, 5: 83–91.
Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 680–685.
Tsai C-M, Frasch CE A sensitive silver stain for detecting lipopolysaccharide in polyacrylamide gels. Analytical Biochemistry 1982, 119: 115–119.
Chart H Serodiagnosis of infections caused byEscherichia coli O157 and other VTEC. Serodiagnosis and Immunotherapy of Infectious Disease 1993, 1: 8–12.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chart, H., van der Kar, N.C.A., Tolboom, J.J.M. et al. Serological detection of verocytotoxin-producingEscherichia coli in patients with haemolytic uraemic syndrome in Western Europe. Eur. J. Clin. Microbiol. Infect. Dis. 12, 707–709 (1993). https://doi.org/10.1007/BF02009386
Issue Date:
DOI: https://doi.org/10.1007/BF02009386